How do microRNAs affect vascular smooth muscle cell biology?

Current Opinion in Lipidology

Volumn 23, Issue 5, 2012, Pages 405-411

  Robinson, Hollie C ^a   Baker, Andrew H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

microRNA; vascular remodelling; vascular smooth muscle cell

Indexed keywords

GROWTH FACTOR; MICRORNA; MICRORNA 143; MICRORNA 145; TRANSCRIPTION FACTOR;

CELL PROLIFERATION; CYTOLOGY; DOWNSTREAM PROCESSING; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HUMAN; NEOINTIMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANIMALS; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VASCULAR DISEASES;

EID: 84866320598     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32835719a1     Document Type: Review

References (45)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 1986; 58:839-845. (Pubitemid 16094213)
3. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001; 107:823-826. (Pubitemid 34084973)
4. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-355. (Pubitemid 39265675)
5. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011; 12:99-110.
6. Tomari Y, Zamore PD. Perspective: machines for RNAi. Genes Dev 2005; 19:517-529. (Pubitemid 40314984)
7. Czech B, Hannon GJ. Small RNA sorting: matchmaking for Argonautes. Nat Rev Genet 2011; 12:19-31.
8. Flynt AS, Lai EC. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet 2008; 9:831-842.
9. Van Rooij E. The art of microRNA research. Circ Res 2011; 108:219-234.
10. Van Rooij E. Introduction to the series on microRNAs in the cardiovascular system. Circ Res 2012; 110:481-482.
11. Cordes KR, Sheehy NT, White MP, Berry EC, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460:705-710.
12. Cheng Y, Liu X, Yang J, Lin Y, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105:158-166.
13. Xin M, Small EM, Sutherland LB, Qi X, et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 2009; 23:2166-2178.
14. Chen J, Yin H, Jiang Y, Radhakrishnan SK, et al. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 2011; 31:368-375.
15. Liu X, Cheng Y, Zhang S, Lin Y, et al. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyper-plasia. Circ Res 2009; 104:476-487.
16. Ji R, Cheng Y, Yue J, Yang J, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 2007; 100:1579-1588. (Pubitemid 46897261)
17. Albinsson S, Skoura A, Yu J, DiLorenzo A, et al. Smooth muscle miRNAs are critical for postnatal regulation of blood pressure and vascular function. PLoS One 2011; 6:e18869.
18. Elia L, Quintavalle M, Zhang J, Contu R, et al. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009; 16:1590-1598.
19. Boettger T, Beetz N, Kostin S, Schneider J, et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009; 119:2634-2647.
20. Quintavalle M, Elia L, Condorelli G, Courtneidge SA. MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol 2010; 189:13-22.
21. Hergenreider E, Heydt S, Treguer K, Boettger T, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012; 14:249-256.
22. Miano JM, Long X, Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 2007; 292:C70-C81. (Pubitemid 46115122)
23. Davis-Dusenbery BN, Chan MC, Reno KE, et al. Down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J Biol Chem 2011; 286:28097-28110.
24. Long X, Miano JM. Transforming growth factor-beta1 (TGF-beta1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells. J Biol Chem 2011; 286:30119-30129.
25. Horita HN, Simpson PA, Ostriker A, Furgeson S, et al. Serum response factor regulates expression of phosphatase and tensin homolog through a micro-RNA network in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2011; 31:2909-2919.
26. Nemenoff RA, Horita H, Ostriker AC, Furgeson SB, et al. SDF-1alpha induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formation. Arterioscler Thromb Vasc Biol 2011; 31:1300-1308.
27. Fujita S, Ito T, Mizutani T, Minoguchi S, et al. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 2008; 378:492-504.
28. Sarkar J, Gou D, Turaka P, Viktorova E, et al. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 2010; 299:L861-L871.
29. Kang H, Davis-Dusenbery BN, Nguyen PH, Lal A, et al. Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating micro-RNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins. J Biol Chem 2012; 287:3976-3986.
30. Boucher JM, Peterson SM, Urs S, Zhang C, et al. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells. J Biol Chem 2011; 286:28312-28321.
31. Wang M, Li W, Chang GQ, Ye CS, et al. MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol 2011; 31:2044-2053.
32. Yang S, Banerjee S, Freitas A, Cui H, et al. miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 2012; 302:L521-L529.
33. Caruso P, MacLean MR, Khanin R, McClure J, et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 2010; 30:716-723.
34. Kotlo KU, Hesabi B, Danziger RS. Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells. Am J Physiol Cell Physiol 2011; 301:C929-C937.
35. Pullamsetti SS, Doebele C, Fischer A, Savai R, et al. Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am J Respir Crit Care Med 2012; 185:409-419.
36. Parikh VN, Jin RC, Rabello S, Gulbahce N, et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 2012; 125:1520-1532.
37. Wu WH, Hu CP, Chen XP, Zhang WF, et al. MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am J Hypertens 2011; 24:1087-1093.
38. Care A, Catalucci D, Felicetti F, Bonci D, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007; 13:613-618. (Pubitemid 46828487)
39. Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010; 18:510-525.
40. Torella D, Iaconetti C, Catalucci D, Ellison GM, et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 2011; 109:880-893.
41. Deaton RA, Gan Q, Owens GK. Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol 2009; 296:H1027-H1037.
42. Jiang Y, Yin H, Zheng XL. MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells. J Cell Physiol 2010; 225:506-511.
43. Sun SG, Zheng B, Han M, Fang XM, et al. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011; 12:56-62.
44. Zampetaki A, Kiechl S, Drozdov I, Willeit P, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010; 107:810-817.
45. Reddy MA, Jin W, Villeneuve L, Wang M, et al. Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice. Arterioscler Thromb Vasc Biol 2012; 32:721-729.